Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC Health October 2, 2024 Adding immunotherapy to chemoradiation therapy (CRT) for limited-stage small cell lung cancer (SCLC) failed to improve survival in a randomized…
Immunotherapy Instills Renewed Promise in SCLC Health September 26, 2024 David R. Spigel, MD Chief Scientific Officer Sarah Cannon Research Institute Nashville, TNWith the emergence of immunotherapy-based regimens in earlier…
